Nethrie Idippily-Singh

Curonbiotech, Inc.

$134,369

Attributed

$268,737

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

NIH$268,737 · 1

By mechanism

R43$268,737 · 1

Top collaborators

David Wald1 shared

Most similar at Curonbiotech, Inc.

Same institution · by research overlap

Yongchun Hou$145,140

Others in their field

Other Emerging Leaders on “Acute Myeloid Leukemia Cell”

Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,329,699
Benjamin G Vincent · Univ Of North Carolina Chapel Hill$3,644,761
Jeffrey Alan Magee · Washington University$3,546,780
Amanda M Schalk · Enzyme By Design, Inc.$3,543,028
Rolf Muller · Biofluidica, Inc$3,253,766

Research focus

Acute Myeloid Leukemia CellAcute Promyelocytic LeukemiaAdultAnimal EfficacyAnimal ModelAwarenessBiologicalBone MarrowBone Marrow CellsCell ModelCellsChemotherapyChronicClinical TrialsColonic NeoplasmsCyclin-Dependent KinasesDifferentiation And GrowthDifferentiation InducerDifferentiation TherapyDoseDrug ResistanceDrug TargetingEfficacy StudyAcute Myelocytic Leukemia

Grant awards (1)

Targeting GSK3 in AML$268,737

R43 · FY2019 · CA · contact PI